Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alcidion Group Limited ( (AU:ALC) ) has shared an update.
Alcidion Group Limited will release its Appendix 4C Quarterly Cash Flow Report for the quarter ended 31 December 2025 (Q2 FY26) on 15 January 2026 and will host a live investor webcast the same day, led by Group Managing Director and CEO Kate Quirke and CFO Matthew Gepp. The webcast will cover operational and commercial highlights for the quarter and include a Q&A session, signalling the company’s ongoing engagement with investors as it continues to scale its healthcare technology footprint across key markets.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is an Australia-based healthcare technology company that develops proactive, smart, and intuitive software solutions to improve the efficiency and quality of patient care for healthcare organisations worldwide. Its flagship product, Miya Precision, underpins a suite of interoperable software and technical services that aggregate clinical information into centralised dashboards, support communication and task management, and provide clinical decision support at the point of care. Since listing on the ASX in 2016, Alcidion has grown through acquisitions and now services more than 400 hospitals and 87 healthcare organisations across the UK, Australia, and New Zealand, with plans for further international expansion.
Average Trading Volume: 647,538
Technical Sentiment Signal: Hold
Current Market Cap: A$134.3M
Find detailed analytics on ALC stock on TipRanks’ Stock Analysis page.